KAKKAR RAHUL (Chief Executive Officer) purchased 14K shares of PANDION THERAPEUTICS, INC. on the open market
Open‑market purchase worth $252.0K. The strongest form of insider conviction signal.
Common Stock
Shares
+21.13K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+14K
Price / share
$18.00
Trade value
$252K
% of position
Net shares
+35.13K
Net value
$252K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/21/2020 | C · Conversion | +21.13K | — | — | 3.1% | 681.38K | 702.51K |
| Common Stock Direct | 7/21/2020 | P · Purchase | +14K | $18.00 | $252K | New position | 0.00 | 14K |
| Total | +35.13K | $252K | ||||||
Stock Option (right to buy)
Common Stock
27.18K shares
Shares
+27.18K
Strike price
18.00
Held after
27.18K
Exercisable
—
Stock Option (right to buy)
Common Stock
221.07K shares
Shares
+221.07K
Strike price
18.00
Held after
221.07K
Exercisable
—
Stock Option (right to buy)
Common Stock
100.49K shares
Shares
+100.49K
Strike price
18.00
Held after
100.49K
Exercisable
—
Series B Preferred Stock
Common Stock
21.13K shares
Shares
−107.77K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock27.18K shares | 7/17/2020 | A · Award | +27.18K | 18.00 | — | 27.18K |
| Stock Option (right to buy) Direct | Common Stock221.07K shares | 7/17/2020 | A · Award | +221.07K | 18.00 | — | 221.07K |
| Stock Option (right to buy) Direct | Common Stock100.49K shares | 7/17/2020 | A · Award | +100.49K | 18.00 | — | 100.49K |
| Series B Preferred Stock Indirect | Common Stock21.13K shares | 7/21/2020 | C · Conversion | −107.77K | — | 0.00 |